|
|
|
Stem Cell Related Patent Number US6023010
| Title: | Transgenic non-human animals depleted in a mature lymphocytic cell-type | | Inventors: | Krimpenfort, Paulus Jacobus Angelinus; Amsterdam, Netherlands
Berns, Antonius Johannes Maria; Spaarndam, Netherlands | | Summary: | This invention introduces novel transgenic nonhuman mammals which are depleted in mature lymphocytic cells, methods and uses thereof. Described herein are transgenic mice having a phenotype characterized by the substantial depletion of a mature lymphocytic cell type otherwise naturally occurring in wild-type mice, and which results from a transgene encoding a lymphatic polypeptide variant which inhibits the formation of lymphocyte cells. Further disclosed are the means by which the phenotype is conferred in the transgenic mouse by a transgene contained in the precursor stem cell of the lymphocytic cell type which is depleted, such that the transgene comprises a DNA sequence encoding a lymphatic polypeptide variant which inhibits maturation of the lymphocytic cell type. Therapeutic and experimental applications are included. | | Abstract: | Transgenic mice having a phenotype characterized by the substantial depletion of a mature lymphocytic cell type otherwise naturally occurring in the species from which the transgenic mouse is derived. The phenotype is conferred in the transgenic mouse by a transgene contained in at least the precursor stem cell of the lymphocytic cell type which is depleted. The transgene comprised is a DNA sequence encoding a lymphatic polypeptide variant which inhibits maturation of the lymphocytic cell type. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6023010 | | Application Number: | US1996000761765 | | Date Filed: | 05/12/1996 | | Date Published: | 08/02/2000 | | Assignee: | GenPharm International Inc., Palo Alto, CA, USA |
|
|
